AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Azilsartan Medoxomil And Chlorthalidone, and when can generic versions of Azilsartan Medoxomil And Chlorthalidone launch?
Azilsartan Medoxomil And Chlorthalidone is a drug marketed by Alkem Labs Ltd and is included in one NDA.
The generic ingredient in AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE is azilsartan kamedoxomil; chlorthalidone. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azilsartan kamedoxomil; chlorthalidone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE?
- What are the global sales for AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE?
- What is Average Wholesale Price for AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE?
Summary for AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
US Patents and Regulatory Information for AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 217490-001 | Jan 21, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alkem Labs Ltd | AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 217490-002 | Jan 21, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
